A Comparative Clinical Evaluation of the Efficacy of Tilshelukarvi Yog and Brahmi Ghrit Nasya in Management of Pushpaghni Jataharini With Special Refrence to Polycystic Ovarian Syndrome (PCOS).
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
- 试验地点
- 1
研究概览
简要总结
This synopsis is a comparative clinical study conducted by Dr. Jyotsna M.S. Ayurveda, Prasuti Tantra & Stri Roga to evaluate the effectiveness of Tilshelukarvi Yog and Brahmi Ghrit Nasya in the management of Polycystic Ovarian Syndrome, which is correlated in Ayurveda with Pushpaghni Jataharini described in Kashyapa Samhita. PCOS is a common hormonal disorder causing irregular menstruation, obesity, excess hair growth, and infertility. According to Ayurveda, it occurs due to imbalance of Vata and Kapha dosha, Agnimandya , and blockage of Artavavaha Srotas. In this randomized comparative clinical study, 40 patients aged 18 to 40 years will be divided into two groups: one receiving Tilshelukarvi Yog orally and the other receiving Tilshelukarvi Yog along with Brahmi Ghrit Nasya therapy. The study will assess improvement in menstrual regularity, hormonal levels, ovarian changes, BMI, and associated symptoms. The aim is to provide a safe, non-hormonal, and effective Ayurvedic approach for long-term management of PCOS with minimal side effects
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 40.00 Year(s)（—）
- 性别
- Female
入选标准
- •1 Females who are in age group 18-40 years.
- •2 Patients having menstrual irregularities in terms of flow, duration and interval.
- •3 Patients having polycystic ovaries diagnosed by USG.
- •4 Patients showing other symptoms of PCOS i.e. facial hairs, acne, obesity, scalp hair loss etc.
- •5 Patients who are willing for trial.
排除标准
- •1 Patients of age below 18 and above 40 years of age.
- •2 Patients having any genetic or congenital deformities or having any other disease causing oligomenorrhea and anovulation.
- •3 Any pelvic pathology TB or carcinoma.
- •4 Patients suffering from systemic disorders like hypertension,Diabetes, hyperprolactinemia, adrenal hyperplasia, thyroid abnormalities, and cardiac diseases are excluded.
- •5 Current or previous ,within last 3 months use of OCP pills, gluco-corticoids, anti androgens, ovulation inducing drugs, or any other hormonal drugs.
- •6 Post-menopausal stage.
研究者
Dr Jyotsna
State Ayurvedic College and Hospital Lucknow